Filed Pursuant to Rule 424(b)(2)
Registration No. 333-212049
PROSPECTUS SUPPLEMENT
(To Prospectus dated June 24, 2016)
1,500,000 Shares
7.00% Series B Cumulative Redeemable Perpetual Preferred Stock
We are offering 1,500,000 shares of our 7.00% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share, or our Series B Preferred Stock, in this offering. This is the original issuance of shares of our Series B Preferred Stock, which have a liquidation preference of $25.00 per share.
Holders of Series B Preferred Stock will be entitled to receive dividend payments only when, as and if authorized by our board of directors and declared by us. We will pay cumulative dividends on the Series B Preferred Stock from the date of original issue at a rate of 7.00% per annum of the $25.00 liquidation preference per share (equivalent to an annual rate of $1.7500 per share). Dividends will be paid quarterly in arrears on the fifteenth (15th) day of January, April, July and October of each year (or if not a business day, on the immediately preceding business day) to holders of record as of the close of business on the first (1st) day of January, April, July and October of each year (or if not a business day, on the next succeeding business day). The first dividend on the Series B Preferred Stock will be paid on the business day immediately preceding April 15, 2018 to holders of record on the business day immediately succeeding April 1, 2018, and will be a pro rata dividend for the period from, and including, the original issue date to, but excluding the business day immediately preceding April 15, 2018, in the amount of $0.37431 per share. Payment of dividends on the Series B Preferred Stock is subject to certain legal and other restrictions as described elsewhere in this prospectus supplement. The Series B Preferred Stock will rank senior to our common stock, par value $0.01 per share, or our common stock, and on parity with our Series A Preferred Stock, par value $0.01 per share, or our Series A Preferred Stock, with respect to dividend rights and rights upon our liquidation, dissolution and winding up.
Generally, we may not redeem the Series B Preferred Stock prior to January 26, 2023, except in limited circumstances to preserve our status as a real estate investment trust, or REIT, and pursuant to the special redemption option described below. On or after January 26, 2023, we may, at our option, redeem the Series B Preferred Stock, in whole or in part, at any time and from time to time, for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends (whether or not authorized or declared) on such Series B Preferred Stock up to, but excluding, the date fixed for redemption, as described under “Description of Series B Preferred Stock — Redemption — Redemption at Our Option.” In addition, upon the occurrence of a Change of Control (as defined herein), we may, at our option, redeem the Series B Preferred Stock for cash, in whole or in part, within 120 days after the first date on which such Change of Control occurred, by paying $25.00 per share, plus any accrued and unpaid dividends (whether or not authorized or declared) to, but excluding, the date fixed for redemption. See “Description of Series B Preferred Stock — Redemption — Special Redemption Option upon a Change of Control.” If we exercise either our optional redemption right or our special redemption option relating to the Series B Preferred Stock, the holders of Series B Preferred Stock will not have the conversion right described below. The shares of our Series B Preferred Stock do not have any maturity date and will remain outstanding indefinitely, unless and until we decide to redeem them or they are converted in connection with a Change of Control by the holders of the Series B Preferred Stock. The Series B Preferred Stock will not have voting rights, except as set forth herein under “Description of Series B Preferred Stock — Limited Voting Rights.”
Upon the occurrence of a Change of Control, each holder of Series B Preferred Stock will have the right to convert some or all of the Series B Preferred Stock held by such holder into shares of our common stock as described herein under “Description of Series B Preferred Stock — Conversion Right upon a Change of Control,” unless, prior to the Change of Control Conversion Date (as defined herein), we have provided or provide notice of our election to redeem the Series B Preferred Stock as described herein under “Description of Series B Preferred Stock — Redemption.”
No current market exists for our Series B Preferred Stock. We have applied to list the Series B Preferred Stock on the New York Stock Exchange, or the NYSE, under the symbol “JCAP PR B.” If the listing application is approved, we expect trading of the Series B Preferred Stock to commence within 30 days after initial delivery of the shares. Our common stock currently trades on the NYSE under the symbol “JCAP.”
We are an “emerging growth company,” as that term is used in the Jumpstart Our Business Startups Act of 2012, and are thus subject to reduced public company reporting requirements. Investing in our Series B Preferred Stock involves substantial risks. See “Risk Factors” beginning on page S-
14 of this prospectus supplement and the risks set forth under the caption “Item 1A. Risk Factors” in our most recent Annual Report on Form 10-K, as well as additional risks that may be described in future reports or information that we file with the Securities and Exchange Commission, including our Quarterly Reports on Form 10-Q, which are incorporated by reference in this prospectus supplement and the accompanying prospectus.
| | | Per Share | | | Total | |
Public offering price | | | | $ | 25.0000 | | | | | $ | 37,500,000 | | |
Underwriting discount and commissions | | | | $ | 0.7875 | | | | | $ | 1,181,250 | | |
Proceeds, before expenses, to us | | | | $ | 24.2125 | | | | | $ | 36,318,750 | | |
We have granted the underwriters an option to purchase up to 225,000 additional shares of our Series B Preferred Stock on the same terms and conditions set forth above for 30 days after the date of this prospectus supplement solely to cover over-allotments, if any.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement and the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters expect to deliver the Series B Preferred Stock through The Depository Trust Company on or about January 26, 2018, which is the fifth business day following the pricing of this offering.
Joint Book-Running Managers
| RAYMOND JAMES | | | MORGAN STANLEY | |
Co-Managers
B. Riley FBRBMO Capital Markets KeyBanc Capital Markets
The date of this prospectus supplement is January 19, 2018.